
Altasciences
Overland Park, KS, United States altasciences.com From their website, Nov 2026
- GLP
Work here? Claim this listing
About
Altasciences is a mid-size contract research organization and CDMO that supports preclinical and clinical drug development, bioanalysis, and manufacturing. It works with biopharmaceutical companies on early-phase programs from preclinical safety testing through Phase I and Phase II, with facilities in Canada and the U.S.
Services
Nonclinical Services
Provides safety assessments and regulatory-ready nonclinical data for small and large molecules.
Lead Optimization Studies
Runs non-GLP screening studies to help select promising drug candidates through PK, toxicology, and dose-response data.
ADME, DMPK & toxicology
Dose Range-Finding Studies
Conducts customized DRF and MTD studies to determine dose range, dose selection, and toxicity findings for IND-enabling work.
ADME, DMPK & toxicology
Preclinical Pharmacology Studies
Performs in vivo efficacy, safety, PK, and safety pharmacology studies in animal models.
ADME, DMPK & toxicology
Pharmacokinetic and Pharmacodynamic Studies
Characterizes exposure-response, ADME, bioavailability, bioequivalence, and toxicokinetics in preclinical models.
ADME, DMPK & toxicology
Clinical Research Services
Provides Phase I, Phase IIa, clinical pharmacology, and NDA-enabling clinical research services.
Proof-of-Concept Clinical Trials
Designs and conducts early-phase proof-of-concept studies using biomarkers, endpoints, patient cohorts, and hybrid site models.
Bioavailability/Bioequivalence Studies
Conducts BA/BE testing for small molecules and biologics, including absolute bioavailability and comparative studies.
15 more services
- Human Abuse Potential Studies
- Drug Product Formulation and Manufacturing Services
- Method Development, Qualification, and Validation
- Over-Encapsulation and Blinded Study Materials
- Pharmaceutical Formulation Development
- Wet Nanomilling and Vial Filling
- Bioanalytical Services
- Research Support Services
- Nonclinical Research Services
- Manufacturing and Analytical Services
- Program Management
- Medical Writing
- Biostatistics
- Clinical Monitoring
- Data Management
- Turnaround
- Reduce drug development timelines by up to 40%
- Move from first safety assessment to clinical proof-of-concept in as little as 18 months
- What to send
- Rabbit plasma
- Participant panels
- Healthy volunteers
- Patients
- Special populations
Capabilities
- Assays and studies
- Bioanalysis
- Toxicology
- LC-MS/MS
- PK/PD
- Oligonucleotides
- Small molecules
17 more
- In vivo
- Antibodies
- Stability studies
- Safety pharmacology
- Bioavailability
- Bioequivalence
- Clinical pathology
- Hematology
- Gross pathology
- Histopathology
- Analytical method validation
- 8-Factor Analyses
- Biomarker analysis
- Ligand-binding
- Immunotoxicology
- Immunology
- Immunogenicity
- Scale and capacity
- Four nonclinical facilities
- 260 custom-designed animal rooms
- 585,000 sq. ft. purpose-built space
- Over 500 employees
- Over 1,000 employees dedicated to clinical pharmacology research
- Over 500 beds across the U.S. and Canada
11 more
- 64,000 square-foot GMP manufacturing facility
- Dosing of up to 72 participants in a single group
- Global network of 300+ active partner sites
- Three North American clinics
- Over 700 nonclinical studies annually
- Over 285 trials per year
- 585,000 square feet of purpose-built space
- 160 custom-designed animal rooms in Seattle
- 80 custom-designed animal rooms in Columbia
- Capacity to house ~3,680 NHPs, ~500 canines, ~12,000 rodents, and ~800 rabbits
- Capacity to house ~200 NHPs, ~700 canines, ~800 swine, ~2,320 rodents, ~300 guinea pigs, and ~100 rabbits
- Therapeutic areas
- Cardiovascular diseases
- Metabolic diseases
- Infectious diseases
- Gene therapy
- Inflammation and autoimmune diseases
- Musculoskeletal diseases
14 more
- Neurology
- Ocular diseases
- Oncology
- Immuno-oncology
- Rare diseases
- Respiratory diseases
- CNS/neurology
- Psychiatry
- Substance abuse
- Cardiology
- Dermatology
- Gastroenterology
- Hematology
- Immunology
Instruments and platforms
- NETZSCH DeltaVita® 15-300 mill
- Qualicaps Model 10
- LC-MS/MS
- Tandem mass spectrometry
- Streptavidin magnetic beads
Modalities and species
- Modalities
- Small molecule
- Antibody
- ADC
- Peptide
- Oligonucleotide
- Vaccine
- Biosimilar
- Species and models
- Rodent
- Non-rodent
- NHPs
- Canines
- Rabbits
- Miniature swine
9 more
- Healthy volunteers
- Patients
- Special populations
- Cell and gene therapy models
- Genetically specific studies
- Non-rodent species
- Swine
- Guinea pigs
- European housing
Certifications
As the company states them, with the certificate or registry record where there is one.
AAALACSelf-reported
GMPSelf-reported
As listed: cGMP
FDA registrationSelf-reported
As listed: FDA-registered
GLPSelf-reported
Company
- Type
- CRDMO
- Founded
- 1992
- Team
- Over 1,000 employees
Locations
- Office
- 1200 Beaumont Avenue Montreal, QC H3P 3P1 Canada
- Sites
- Montréal, Canada
- Laval, Canada
- Everett, United States
- Harleysville, United States
- Cypress, United States
- Scott Township, United States
5 more
- Auxvasse, United States
- Sacramento, United States
- Kansas City, United States
- Seattle, United States
- Philadelphia, United States
- Serves
- Canada, United States, North America, global, U.S.